Colgate-Palmolive Company vs. cbdMD, Inc. Common Stock
Colgate-Palmolive Company (CL) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CL | YCBD | |
|---|---|---|
| Market Cap | $69.37 billion | $5.40 million |
| Revenue (TTM) | $21.05 billion | — |
| Net Income (TTM) | $2.16 billion | — |
CL leads on 1 of 1 size & scale factors.
Valuation
| CL | YCBD | |
|---|---|---|
| P/E Ratio | 34.68 | — |
| Price / Book | 122.56 | — |
| Price / Sales | 3.30 | — |
CL and YCBD split the valuation factors evenly.
Profitability
| CL | YCBD | |
|---|---|---|
| Net Margin | 10.27% | — |
| Return on Equity | 381.80% | — |
CL and YCBD split the profitability factors evenly.
Dividend
| CL | YCBD | |
|---|---|---|
| Dividend Yield | 2.42% | — |
| Payout Ratio | 83.79 | — |
CL and YCBD split the dividend factors evenly.
Risk & Sentiment
| CL | YCBD | |
|---|---|---|
| Short Interest | 1.08% | 3.64% |
CL leads on 1 of 1 risk & sentiment factors.
Dig deeper: CL overview, CL financials, YCBD overview, YCBD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.